The global Grave’s disease diagnosis and treatment market size was $745.0 million in 2021 and is growing at a modest CAGR of 4.2% during the forecast period. Various research institutes are performing R&D on thyroid diagnosis and treatment. For instance, the American Thyroid Association is focused on research for the diagnosis and treatment of thyroid disease. American Thyroid Association has received more than 99 thyroid research grants accounting for $2.6 million. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is working with the American Thyroid Association to perform research based on thyroid diseases. American Thyroid Association has received funding from the Thyroid Cancer Survivors’ Association, Inc., Bite Me Cancer, and Thyroid Head and Neck Cancer Foundation. Since, 2003, Thyroid Cancer Survivors’ Association, Inc. has awarded 72.5 special research grants focused on thyroid cancer and medullary thyroid cancer accounting for approximately $2 million.
Browse the full report description of “Grave’s Disease Diagnosis and Treatment Market Size, Share & Trends Analysis Report by Diagnosis (Ultrasound, Imaging Test, RIAU, and Blood Sample), By Treatment (Anti-Thyroid Medication, Radioactive Iodine Therapy, and Surgery), Forecast Period (2023-2029)” at https://www.omrglobal.com/industry-reports/graves-disease-diagnosis-and-treatment-market
Recently, in 2018 along with Bite Me Cancer, Thyroid Cancer Survivors’ Association, Inc. is supporting a new medullary thyroid cancer grant. Further, Thyroid Cancer Survivors’ Association, Inc. is awarding two new thyroid cancer research grants, and three renewing grants to the American Thyroid Association. Such intense R&D performed by major research organizations on the thyroid is significantly contributing to the market.
Market Coverage
• The market number available for – 2023-2029
• Base year- 2022
• Forecast period- 2023-2029
• Segment Covered-
o By Diagnosis
o By Treatment
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Rodos Biotarget GmbH, Sanofi Genzyme, Macleods Pharmaceuticals Ltd., Apitope International N.V., RLC Labs Inc. Takeda Pharmaceutical Co., Ltd., and Omeros Corp.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected regions and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Grave’s Disease Diagnosis and Treatment Market Report Segment
By Diagnosis
By Treatment
Global Grave’s Disease Diagnosis and Treatment Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/graves-disease-diagnosis-and-treatment-market